Ribosome display
Ribosome display is a technique used to perform in vitro protein evolution to create proteins that can bind to a desired ligand. The process results in translated proteins that are associated with their mRNA progenitor which is used, as a complex, to bind to an immobilized ligand in a selection step. The mRNA-protein hybrids that bind well are then reverse transcribed to cDNA and their sequence amplified via PCR.[1] The result is a nucleotide sequence that can be used to create tightly binding proteins.
Ribosome display process
Ribosome display begins with a native library of DNA sequences coding for polypeptides.[2] Each sequence is transcribed, and then translated in vitro into a polypeptide. However, the DNA library coding for a particular library of binding proteins is genetically fused to a spacer sequence lacking a stop codon before its end. The lack of a stop codon prevents release factors from binding and triggering the disassembly of the translational complex. So, this spacer sequence stays attached to the peptidyl tRNA and occupies the ribosomal tunnel, and thus allows the protein of interest to protrude out of the ribosome and fold. What results is a complex of mRNA, ribosome, and protein which can bind to surface-bound ligand. This complex is stabilized with the lowering of temperature and the addition of cations such as Mg2+.
During the subsequent binding, or panning, stages, the complex is introduced to a surface-bound ligand. This can be accomplished in several ways, for example using an affinity chromatography column with a resin bed containing ligand, a 96-well plate with immobilized surface-bound ligand, or magnetic beads that have been coated with ligand. The complexes that bind well are immobilized. Subsequent elution of the binders via high salt concentrations, chelating agents, or mobile ligands which complex with the binding motif of the protein allow dissociation of the mRNA. The mRNA can then be reverse transcribed back into cDNA, undergo mutagenesis, and iteratively fed into the process with greater selective pressure to isolate even better binders.
Advantages of ribosome display
By having the protein progenitor attached to the complex, the processes of ribosome display skips the microarray/peptide bead/multiple-well sequence separation that is common in assays involving nucleotide hybridization and provides a ready way to amplify the proteins that do bind without decrypting the sequence until necessary. At the same time, this method relies on generating large, concentrated pools of sequence diversity without gaps and keeping these sequences from degrading, hybridizing, and reacting with each other in ways that would create sequence-space gaps.
It has a successful track record in the engineering of antibody[3] and protein therapeutic [4] leads and is still widely used in these areas.
Competing methods for protein evolution in vitro are phage display, yeast display, bacterial display, and mRNA display.[5] peptides (Mattheakis, Bhatt and Dow) As it is performed entirely in vitro, there are two main advantages over other selection technologies. First, the diversity of the library is not limited by the transformation efficiency of bacterial cells, but only by the number of ribosomes and different mRNA molecules present in the test tube. Second, random mutations can be introduced easily after each selection round, as no library must be transformed after any diversification step. This allows facile directed evolution of binding proteins over several generations.
A prerequisite for the selection of proteins from libraries is the coupling of genotype (RNA, DNA) and phenotype (protein). In ribosome display, this link is accomplished during in vitro translation by stabilizing the complex consisting of the ribosome, the mRNA and the nascent, correctly folded polypeptide. The ribosomal complexes are allowed to bind to surface-immobilized target. Whereas non-bound complexes are washed away, mRNA of the complexes displaying a binding polypeptide can be recovered, and thus, the genetic information of the binding polypeptides is available for analysis.
See also
References
- Hanes, J.; Plückthun, A. (1997). "In vitro selection and evolution of functional proteins by using ribosome display". Proc. Natl. Acad. Sci. U.S.A. 94 (10): 4937–42. doi:10.1073/pnas.94.10.4937. PMC 24609. PMID 9144168.
- Lipovsek, D.; Plückthun, A. (2004). "In-vitro protein evolution by ribosome display and mRNA display". J. Immunol. Methods. 290 (1–2): 51–67. doi:10.1016/j.jim.2004.04.008. PMID 15261571.
- He, M.; Taussig, M. (2007). "Eukaryotic ribosome display with in situ DNA recovery". Nature Methods. 4 (3): 281–288. doi:10.1038/nmeth1001. PMID 17327849. S2CID 7293661.
- ^ X Yan; Z Xu (2006). "Ribosome-display technology: applications for directed evolution of functional proteins". Drug Discovery Today. 11 (19–20): 911–916. doi:10.1016/j.drudis.2006.08.012. PMID 16997141.
- ^ L C Mattheakis; R R Bhatt & W J Dower (September 1994). "An in vitro polysome display system for identifying ligands from very large peptide libraries". Proceedings of the National Academy of Sciences. 91 (19): 9022–6. doi:10.1073/pnas.91.19.9022. PMC 44739. PMID 7522328.
- ^ Jermutus, Lutz; Honegger, Annemarie; Schwesinger, Falk; Hanes, Jozef; Plückthun, Andreas (2001-01-02). "Tailoring in vitro evolution for protein affinity or stability". Proceedings of the National Academy of Sciences. 98 (1): 75–80. doi:10.1073/pnas.98.1.75. ISSN 0027-8424. PMC 14547. PMID 11134506.
- ^ Buchanan, Andrew; Ferraro, Franco; Rust, Steven; Sridharan, Sudharsan; Franks, Ruth; Dean, Greg; McCourt, Matthew; Jermutus, Lutz; Minter, Ralph (2012-08-31). "Improved drug-like properties of therapeutic proteins by directed evolution". Protein Engineering Design and Selection. 25 (10): 631–638. doi:10.1093/protein/gzs054. ISSN 1741-0126. PMC 3449403. PMID 22942395.
- ^ Jing D, Li F, Jiang M, Cai J, Wu Y, Xie K, Wu X, Tang C, Liu J, Guo W, Shen G, Luo E (November 2013). "Pulsed Electromagnetic Fields Improve Bone Microstructure And Strength In Ovariectomized Rats". PLOS ONE. 8 (11): e79377. doi:10.1371/journal.pone.0079377. PMC 3828367. PMID 24244491.